Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension, September 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 149 articles:
HTML format


 

Single Articles

  1. PAPAKONSTANTINOU N, Kampaktsis P, Rorris FP, Doulamis I, et al
    Surgical Treatment of Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension.
    Curr Pharm Des. 2021 Sep 2. pii: CPD-EPUB-117644.
    PubMed    
    Abstract available

  2. VAHDATPOUR CA, Ryan JJ, Zimmerman JM, MacCormick SJ, et al
    Advanced airway management and respiratory care in decompensated pulmonary hypertension.
    Heart Fail Rev. 2021 Sep 2. pii: 10.1007/s10741-021-10168.
    PubMed    
    Abstract available

  3. STUBBS H, Church C, Johnson M, Thomson S, et al
    Impairment of skeletal muscle oxygen extraction and cardiac output are matched in precapillary pulmonary hypertension.
    ERJ Open Res. 2021;7.
    PubMed    
    Abstract available

  4. ARSHAD MS, Adnan M, Anwar-Ul-Haq HM, Zulqarnain A, et al
    Postnatal causes and severity of persistent pulmonary Hypertension of Newborn.
    Pak J Med Sci. 2021;37:1387-1391.
    PubMed    
    Abstract available

  5. PLACIDO R, Guimaraes T, Jenkins D, Cortez-Dias N, et al
    Chronic thromboembolic pulmonary hypertension: initial experience of patients undergoing pulmonary thromboendarterectomy.
    Rev Port Cardiol. 2021 Aug 30. pii: S0870-2551(21)00248.
    PubMed    
    Abstract available

  6. SWEATT AJ, Reddy R, Rahaghi FN, Al-Naamani N, et al
    What's new in pulmonary hypertension clinical research: lessons from the best abstracts at the 2020 American Thoracic Society International Conference.
    Pulm Circ. 2021;11:20458940211040713.
    PubMed    
    Abstract available

  7. SCHULZE KM, Weber RE, Colburn TD, Horn AG, et al
    The effects of pulmonary hypertension on skeletal muscle oxygen pressures in contracting rat spinotrapezius muscle.
    Exp Physiol. 2021 Sep 1. doi: 10.1113/EP089631.
    PubMed    
    Abstract available

  8. LESAGE F, Deng Y, Renesme L, Sauvestre F, et al
    Characterization of a New Monocrotaline Rat Model to Study Chronic Neonatal Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2021;65:331-334.
    PubMed    


  9. STEELE NZR, Luks AM
    An Anomalous Cause of Pulmonary Hypertension.
    Ann Am Thorac Soc. 2021;18:1571-1576.
    PubMed    


  10. KANAI A, Koitabashi N, Akagi S, Sorimachi H, et al
    A case of a middle-aged patient with a ventricular septal defect complicated by severe pulmonary hypertension-stepwise surgical repair with pulmonary vasodilators.
    J Cardiol Cases. 2021;24:131-135.
    PubMed    
    Abstract available

  11. STRITZKE A, Mills L
    Large Left Ventricular Thrombus in a Neonate - A Rare Complication of Severe Persistent Pulmonary Hypertension of the Neonate.
    Indian Pediatr. 2021;58:793.
    PubMed    


  12. EKICI B
    Can a patient with pulmonary hypertension travel safely by plane?
    Anatol J Cardiol. 2021;25.
    PubMed    
    Abstract available

  13. RAIMONDI F, Conti C, Novelli L, Tarantini F, et al
    A 57-year-old man with rapidly progressive pulmonary hypertension.
    Monaldi Arch Chest Dis. 2021 Aug 9. doi: 10.4081/monaldi.2021.1930.
    PubMed    
    Abstract available

  14. MORALES-DEMORI R, Mallory GB, Chartan C, Coleman R, et al
    "Outcomes of COVID-19 Infection in pediatric pulmonary hypertension: a single-center experience".
    Pediatr Pulmonol. 2021 Aug 30. doi: 10.1002/ppul.25650.
    PubMed    
    Abstract available

  15. KOIKE H, Sueyoshi E, Nishimura T, Iwano Y, et al
    Effect of Balloon Pulmonary Angioplasty on Homogenization of Lung Perfusion Blood Volume by Dual-Energy Computed Tomography in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Lung. 2021 Aug 30. pii: 10.1007/s00408-021-00471.
    PubMed    
    Abstract available

  16. DONG S, Dai X, Jiang Y, Zheng J, et al
    Idiopathic fibrous mediastinitis with refractory pleural effusion: a case report and literature review.
    J Int Med Res. 2021;49:3000605211040264.
    PubMed    
    Abstract available

  17. HOU C, Chen J, Zhao Y, Niu Y, et al
    The Emerging Role of Fatty Acid Synthase in Hypoxia-Induced Pulmonary Hypertensive Mouse Energy Metabolism.
    Oxid Med Cell Longev. 2021;2021:9990794.
    PubMed    
    Abstract available

  18. WANG S, Wang Y, Liu C, Xu G, et al
    EPAS1 (Endothelial PAS Domain Protein 1) Orchestrates Transactivation of Endothelial ICAM1 (Intercellular Adhesion Molecule 1) by Small Nucleolar RNA Host Gene 5 (SNHG5 ) to Promote Hypoxic Pulmonary Hypertension.
    Hypertension. 2021 Aug 30:HYPERTENSIONAHA12116949.
    PubMed    
    Abstract available

  19. CONDE RE, Diez M, Duenas R, Giacomi G, et al
    [Relevance of right ventricle in the clinical management of pulmonary arterial hypertension].
    Medicina (B Aires). 2021;81:624-636.
    PubMed    
    Abstract available

  20. MORA B, Roth D, Bernardi MH, Base E, et al
    Estimation of pulmonary artery pressure with transesophageal echocardiography: An observer-blinded test accuracy study.
    Medicine (Baltimore). 2021;100:e26988.
    PubMed    
    Abstract available

  21. AGNEW C, Ayaz P, Kashima R, Loving HS, et al
    Structural basis for ALK2/BMPR2 receptor complex signaling through kinase domain oligomerization.
    Nat Commun. 2021;12:4950.
    PubMed    
    Abstract available

  22. CAO J, Yang L, Wang L, Zhao Q, et al
    Heat shock protein 70 attenuates hypoxiainduced apoptosis of pulmonary microvascular endothelial cells isolated from neonatal rats.
    Mol Med Rep. 2021;24.
    PubMed    
    Abstract available

  23. SHARMIN N, Nganwuchu CC, Nasim MT
    Targeting the TGF-beta signaling pathway for resolution of pulmonary arterial hypertension.
    Trends Pharmacol Sci. 2021;42:510-513.
    PubMed    
    Abstract available

  24. ZHANG Y, Jin Q, Zhao Z, Zhao Q, et al
    Exercise pathophysiology differs between connective tissue diseases-associated pulmonary arterial hypertension and idiopathic pulmonary arterial hypertension.
    Clin Exp Rheumatol. 2021;39:1063-1070.
    PubMed    
    Abstract available

  25. GHIRARDELLO S, Raffaeli G, Crippa BL, Gulden S, et al
    The Thromboelastographic Profile at Birth in Very Preterm Newborns with Patent Ductus Arteriosus.
    Neonatology. 2020 Jun 2:1-8. doi: 10.1159/000507553.
    PubMed    
    Abstract available

  26. JIANG H, Yu X, Zhang L, Wang M, et al
    Effects of treprostinil on pulmonary arterial hypertension during surgery for congenital heart disease complicated with severe pulmonary arterial hypertension.
    Minerva Cardiol Angiol. 2021;69:154-160.
    PubMed    
    Abstract available

  27. HAKGOR A, Tokgoz HC, Akbal OY, Tanyeri S, et al
    Sustained response to targeted therapies in a patient with pulmonary hypertension owing to Langerhans cell histiocytosis.
    Anatol J Cardiol. 2021;25:665-668.
    PubMed    


  28. CHEN J, Jiang W, Zhu F, Wang Q, et al
    Curcumin Improves Pulmonary Hypertension Rats by Regulating Mitochondrial Function.
    Biomed Res Int. 2021;2021:1078019.
    PubMed    
    Abstract available

  29. LI Y, Liang L, Guo D, Yang Y, et al
    Right Ventricular Function Predicts Adverse Clinical Outcomes in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Three-Dimensional Echocardiographic Study.
    Front Med (Lausanne). 2021;8:697396.
    PubMed    
    Abstract available

  30. SCUDELLER PG, Terra-Filho M, Freitas Filho O, Galas FRBG, et al
    Chronic thromboembolic pulmonary hypertension: the impact of advances in perioperative techniques in patient outcomes.
    J Bras Pneumol. 2021;47:e20200435.
    PubMed    
    Abstract available

  31. WONG TTC, Ng YHG, Yan L, Wright A, et al
    Whooping cough complicating pulmonary hypertension in pregnancy.
    BMJ Case Rep. 2021;14.
    PubMed    
    Abstract available

  32. MANDURINO-MIRIZZI A, Crimi G, Raineri C, Magrini G, et al
    The hemodynamic impact of MitraClip in patients with functional mitral regurgitation and pulmonary hypertension.
    Eur J Clin Invest. 2021 Sep 6:e13676. doi: 10.1111/eci.13676.
    PubMed    
    Abstract available

  33. JERNIGAN NL, Naik JS, Resta TC
    Acid-sensing ion channel 1 contributes to pulmonary arterial smooth muscle cell depolarization following hypoxic pulmonary hypertension.
    J Physiol. 2021 Sep 6. doi: 10.1113/JP282231.
    PubMed    
    Abstract available

  34. YUCHI Y, Suzuki R, Kanno H, Teshima T, et al
    Right Ventricular Myocardial Adaptation Assessed by Two-Dimensional Speckle Tracking Echocardiography in Canine Models of Chronic Pulmonary Hypertension.
    Front Vet Sci. 2021;8:727155.
    PubMed    
    Abstract available

  35. MAMAZHAKYPOV A, Hein L, Lother A
    Mineralocorticoid receptors in pulmonary hypertension and right heart failure: From molecular biology to therapeutic targeting.
    Pharmacol Ther. 2021 Sep 1:107987. doi: 10.1016/j.pharmthera.2021.107987.
    PubMed    
    Abstract available

  36. BURGER CD, DuBrock HM, Cartin-Ceba R, Moss JE, et al
    Topic-Based, Recent Literature Review on Pulmonary Hypertension.
    Mayo Clin Proc. 2021 Aug 31. pii: S0025-6196(21)00437.
    PubMed    
    Abstract available

  37. SANCHEZ-GLORIA JL, Martinez-Olivares CE, Rojas-Morales P, Hernandez-Pando R, et al
    Anti-Inflammatory Effect of Allicin Associated with Fibrosis in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  38. MAMAZHAKYPOV A, Sommer N, Assmus B, Tello K, et al
    Novel Therapeutic Targets for the Treatment of Right Ventricular Remodeling: Insights from the Pulmonary Artery Banding Model.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  39. GILBERT JD, Neubauer K, Byard RW
    Macroscopic identification of visceral titanium pigment in an intravenous drug user.
    J Forensic Sci. 2021;66:2024-2028.
    PubMed    
    Abstract available

  40. BARLOW A, Barlow B, Koyfman A, Long B, et al
    Pulmonary arterial hypertension in the emergency department: A focus on medication management.
    Am J Emerg Med. 2021;47:101-108.
    PubMed    
    Abstract available

  41. PASCALL E, Jones MI, Savis A, Rosenthal E, et al
    Transcatheter creation of a pulmonary artery to left atrial fenestration in a failing Fontan circulation using the Atrial Flow Regulator (AFR).
    Cardiol Young. 2021;31:1376-1379.
    PubMed    
    Abstract available

  42. DIAZ-FRIAS J, Mark PR, Aregullin EO
    Two cases of different genetic variants of alveolar capillary dysplasia associated with left-sided obstructive CHDs.
    Cardiol Young. 2021;31:1368-1370.
    PubMed    
    Abstract available

  43. GE L, Jiang W, Zhang S, Wang J, et al
    Mesenchymal Stromal Cell-derived Exosomes Attenuate Experimental Pulmonary Arterial Hypertension.
    Curr Pharm Biotechnol. 2021;22:1654-1662.
    PubMed    
    Abstract available

  44. KIM HY, Kim KH, Kim J, Park JC, et al
    Multimodality cardiovascular imaging in pulmonary embolism.
    Cardiol J. 2021;28:150-160.
    PubMed    
    Abstract available

  45. GUMAUSKIENE B, Drebickaite E, Pangonyte D, Vaskelyte JJ, et al
    The association of left ventricular histologically verified myocardial fibrosis with pulmonary hypertension in severe aortic stenosis.
    Perfusion. 2021 Sep 15:2676591211042733. doi: 10.1177/02676591211042733.
    PubMed    
    Abstract available

  46. MINATSUKI S, Takahara M, Kiyosue A, Kodera S, et al
    Characteristics and in-hospital outcomes of patients undergoing balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a time-trend analysis from the Japanese nationwide registry.
    Open Heart. 2021;8.
    PubMed    
    Abstract available

  47. YE W, Tang T, Li Z, Li X, et al
    Piperlongumine attenuates vascular remodeling in hypoxic pulmonary hypertension by regulating autophagy.
    J Cardiol. 2021 Sep 10. pii: S0914-5087(21)00226.
    PubMed    
    Abstract available

  48. CSOSZA G, Lazar Z, Rozgonyi Z, Vago H, et al
    Right ventricular adaptation in pulmonary arterial hypertension
    Orv Hetil. 2021;162:1485-1493.
    PubMed    
    Abstract available

  49. ZHENG Z, Chen R, Li C, Lu J, et al
    Sleep-Disordered Breathing in Precapillary Pulmonary Hypertension: Is the Prevalence So High?
    Respiration. 2021;100:1041-1042.
    PubMed    


  50. CHEN Y, Li F, Luo J, Chen J, et al
    Comparative Efficacy and Safety of Targeted Therapies for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Network Meta-Analysis.
    Can Respir J. 2021;2021:1626971.
    PubMed    
    Abstract available

  51. WANG Q, Zhang M, Zhai M, Li Z, et al
    Cerebral infarction caused by systemic sclerosis: a case report.
    J Int Med Res. 2021;49:3000605211044045.
    PubMed    
    Abstract available

  52. AREVALO C, White RJ, Le T, Lachant D, et al
    Vasodilator use in precapillary pulmonary hypertension with end stage kidney disease: A single center experience.
    Respir Med. 2021;188:106596.
    PubMed    
    Abstract available

  53. CANNON DT, Nogueira L, Gutierrez-Gonzalez AK, Gilmore NK, et al
    Role of IL-33 receptor (ST2) deletion in diaphragm contractile and mitochondrial function in the Sugen5416/hypoxia model of pulmonary hypertension.
    Respir Physiol Neurobiol. 2021;295:103783.
    PubMed    
    Abstract available

  54. MATSUGUMA C, Takahashi K, Okada S, Hasegawa S, et al
    Severe persistent pulmonary hypertension in a neonate with Rubinstein-Taybi syndrome accompanied by triple X syndrome.
    Pediatr Neonatol. 2021 Sep 2. pii: S1875-9572(21)00164.
    PubMed    


  55. JIANG X, Zhu YJ, Zhou YP, Peng FH, et al
    Clinical features and survival in Takayasu's arteritis-associated pulmonary hypertension: a nationwide study.
    Eur Heart J. 2021 Sep 10. pii: 6368314. doi: 10.1093.
    PubMed    
    Abstract available

  56. OKNINSKA M, Zambrowska Z, Zajda K, Paterek A, et al
    Right ventricular myocardial oxygen tension is reduced in monocrotaline-induced pulmonary hypertension in the rat and restored by myo-inositol trispyrophosphate.
    Sci Rep. 2021;11:18002.
    PubMed    
    Abstract available

  57. KOSTRUBIEC M
    May-Thurner Anatomy: An Undervalued Anatomical Variant in Patients With Chronic Thromboembolic Pulmonary Hypertension?
    JACC Cardiovasc Interv. 2021;14:1947-1949.
    PubMed    


  58. AL-OTAIBI M, Vaidy A, Vaidya A, Zlotshewer B, et al
    May-Thurner Anatomy in Patients With Chronic Thromboembolic Pulmonary Hypertension: An Important Clinical Association.
    JACC Cardiovasc Interv. 2021;14:1940-1946.
    PubMed    
    Abstract available

  59. KIM NH
    Balloon pulmonary angioplasty - welcome to chronic thromboembolic pulmonary hypertension treatment.
    Rev Port Cardiol (Engl Ed). 2021;40:667-668.
    PubMed    


  60. CALE R, Ferreira F, Pereira AR, Saraiva C, et al
    Balloon pulmonary angioplasty protocol in a Portuguese pulmonary hypertension expert center.
    Rev Port Cardiol (Engl Ed). 2021;40:653-665.
    PubMed    
    Abstract available

  61. LIU P, Li S, Tang L
    Nerve Growth Factor: A Potential Therapeutic Target for Lung Diseases.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  62. RALLIDIS LS, Papangelopoulou K, Makavos G, Varounis C, et al
    Low-Dose Dobutamine Stress Echocardiography for the Early Detection of Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis Whose Resting Echocardioraphy Is Non-Diagnostic for Pulmonary Hypertension.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  63. WEBER L, Rickli H, Haager PK, Joerg L, et al
    Hemodynamics Prior to Valve Replacement for Severe Aortic Stenosis and Pulmonary Hypertension during Long-Term Follow-Up.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  64. RADEGRAN G
    [National consensus created regarding PAH and CTEPH care].
    Lakartidningen. 2021;118.
    PubMed    
    Abstract available

  65. MIYAZAKI S
    [Tyrosine kinase inhibitor-associated cardiovascular adverse events in chronic myeloid leukemia].
    Rinsho Ketsueki. 2021;62:1024-1028.
    PubMed    
    Abstract available

  66. LUO C, Wu W, Wu C, Qiu H, et al
    Liver dysfunction in idiopathic pulmonary arterial hypertension: prevalence, characteristics and prognostic significance, a retrospective cohort study in China.
    BMJ Open. 2021;11:e045165.
    PubMed    
    Abstract available

  67. CONDORI LEANDRO HI, Koshevaya EG, Mitrofanova LB, Vakhrushev AD, et al
    An Ovine Model for Percutaneous Pulmonary Artery Laser Denervation: Perivascular Innervation and Ablation Lesion Characteristics.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  68. MELTON E, Qiu H
    Interleukin-1beta in Multifactorial Hypertension: Inflammation, Vascular Smooth Muscle Cell and Extracellular Matrix Remodeling, and Non-Coding RNA Regulation.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  69. DIEKMANN F, Chouvarine P, Sallmon H, Meyer-Kobbe L, et al
    Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  70. LIAO YX, Wang XH, Bai Y, Lin F, et al
    Relationship Between Endogenous Hydrogen Sulfide and Pulmonary Vascular Indexes on High-Resolution Computed Tomography in Patients with Chronic Obstructive Pulmonary Disease.
    Int J Chron Obstruct Pulmon Dis. 2021;16:2279-2289.
    PubMed    
    Abstract available

  71. EDEMSKIY A, Vasiltseva O, Kliver E, Novikova N, et al
    Pulmonary angiosarcoma: A case report of surgical treatment.
    J Card Surg. 2021;36:3936-3938.
    PubMed    
    Abstract available

  72. BOEHM M, Tian X, Ali MK, Mao Y, et al
    Improving Right Ventricular Function by Increasing BMP Signaling with FK506.
    Am J Respir Cell Mol Biol. 2021;65:272-287.
    PubMed    
    Abstract available

  73. HAN S, Chandel NS
    Lessons from Cancer Metabolism for Pulmonary Arterial Hypertension and Fibrosis.
    Am J Respir Cell Mol Biol. 2021;65:134-145.
    PubMed    
    Abstract available

  74. YANG JZ, Fernandes TM, Kim NH, Poch DS, et al
    Pregnancy and pulmonary arterial hypertension: a case series and literature review.
    Am J Obstet Gynecol MFM. 2021;3:100358.
    PubMed    
    Abstract available

  75. RENNIE GR, Barden TC, Bernier SG, Carvalho A, et al
    Discovery of CYR715: A novel carboxylic acid-containing soluble guanylate cyclase stimulator.
    Bioorg Med Chem Lett. 2021;40:127886.
    PubMed    
    Abstract available

  76. MCCABE C
    Therapeutic use of oxygen in pulmonary arterial hypertension: a forgotten friend.
    Eur J Prev Cardiol. 2021;28:124-126.
    PubMed    


  77. GULIYEVA A, Cakir E, Yazan H, AlShadfan L, et al
    Assessment of Right Heart Functions in Children with Mild Cystic Fibrosis.
    Klin Padiatr. 2021;233:231-236.
    PubMed    
    Abstract available

  78. PAPATHANASIOU AE, Spyropoulos F, Michael Z, Joung KE, et al
    Adipokines and Metabolic Regulators in Human and Experimental Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  79. GUPTA SK, Sachdeva S, Juneja R
    Atrial flutter: yet another cause of arterial desaturation in atrial septal defect.
    Cardiol Young. 2021;31:1027-1029.
    PubMed    
    Abstract available

  80. LIU Y, Nie X, Zhu J, Wang T, et al
    NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension.
    J Cell Mol Med. 2021;25:1221-1237.
    PubMed    
    Abstract available

  81. SUN N, Chen Y, Fan Y, Chang J, et al
    Plasma irisin levels are associated with hemodynamic and clinical outcome in idiopathic pulmonary arterial hypertension patients.
    Intern Emerg Med. 2021;16:625-632.
    PubMed    
    Abstract available

  82. GONCALVES AESS, Rocha GZ, Marin R, Camargo RL, et al
    Pulmonary Hypertension in Obese Mice Is Accompanied by a Reduction in PPAR-gamma Expression in Pulmonary Artery.
    Front Endocrinol (Lausanne). 2021;12:701994.
    PubMed    
    Abstract available

  83. APPLEGATE TJ, Krafsur GM, Boon JA, Zhang H, et al
    Brief Report: Case Comparison of Therapy With the Histone Deacetylase Inhibitor Vorinostat in a Neonatal Calf Model of Pulmonary Hypertension.
    Front Physiol. 2021;12:712583.
    PubMed    
    Abstract available

  84. TURA-CEIDE O, Smolders VFED, Aventin N, Moren C, et al
    Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmonary hypertension.
    Sci Rep. 2021;11:18797.
    PubMed    
    Abstract available

  85. XU J, Desmond EL, Wong TC, Neill CG, et al
    Right Ventricular Shape Feature Quantification for Evaluation of Pulmonary Hypertension: Feasibility and Preliminary Associations with Clinical Outcome Submitted for Publication.
    J Biomech Eng. 2021 Sep 22. pii: 1120496. doi: 10.1115/1.4052495.
    PubMed    
    Abstract available

  86. BAI Y, Wang J, Chen Y, Lv T, et al
    The miR-182/Myadm axis regulates hypoxia-induced pulmonary hypertension by balancing the BMP- and TGF-beta-signalling pathways in an SMC/EC-crosstalk-associated manner.
    Basic Res Cardiol. 2021;116:53.
    PubMed    
    Abstract available

  87. WALTER K
    Pulmonary Hypertension.
    JAMA. 2021;326:1116.
    PubMed    


  88. KAULINS R, Vitola B, Lejniece S, Lejnieks A, et al
    Chronic Thromboembolic Pulmonary Hypertension Mimicking Acute Pulmonary Embolism: A Case Report.
    Am J Case Rep. 2021;22:e933031.
    PubMed    
    Abstract available

  89. FUKUMOTO Y
    Takayasu arteritis-associated pulmonary hypertension.
    Eur Heart J. 2021 Sep 20. pii: 6372800. doi: 10.1093.
    PubMed    


  90. HARDACRE CJ, Robertshaw JA, Barratt SL, Adams HL, et al
    Diagnostic test accuracy of artificial intelligence analysis of cross-sectional imaging in pulmonary hypertension: a systematic literature review.
    Br J Radiol. 2021 Sep 19:20210332. doi: 10.1259/bjr.20210332.
    PubMed    
    Abstract available

  91. ZHANG HJ, Huang R, Liang L, Zhou F, et al
    Vision loss as the initial presentation during primary pulmonary hypertension treatment.
    Int J Ophthalmol. 2021;14:1460-1462.
    PubMed    


  92. BUYSSE J, Billa RD, McLennan D, Ashwath R, et al
    Infantile Scimitar Syndrome With Contralateral Pulmonary Vein Stenosis and Refractory Pulmonary Hypertension.
    Cureus. 2021;13:e17203.
    PubMed    
    Abstract available

  93. LI Y, Li Y, Li L, Yin M, et al
    PKR deficiency alleviates pulmonary hypertension via inducing inflammasome adaptor ASC inactivation.
    Pulm Circ. 2021;11:20458940211046156.
    PubMed    
    Abstract available

  94. MORGAN RW, Himebauch AS, Griffis H, Quarshie WO, et al
    Pulmonary hypertension among children with in-hospital cardiac arrest: a multicenter study.
    Resuscitation. 2021 Sep 15. pii: S0300-9572(21)00363.
    PubMed    
    Abstract available

  95. ASMAT H, Fayeye F, Alshakaty H, Patel J, et al
    A rare case of COVID-19 vaccine-induced thrombotic thrombocytopaenia (VITT) involving the veno-splanchnic and pulmonary arterial circulation, from a UK district general hospital.
    BMJ Case Rep. 2021;14.
    PubMed    
    Abstract available

  96. FREDERIKSEN CA, Waziri F, Ringgaard S, Mellemkjaer S, et al
    Reverse remodeling of tricuspid valve morphology and function in chronic thromboembolic pulmonary hypertension patients following pulmonary thromboendarterectomy: a cardiac magnetic resonance imaging and invasive hemodynamic study.
    BMC Cardiovasc Disord. 2021;21:450.
    PubMed    
    Abstract available

  97. AARONSON PI
    Pulmonary hypertension associated with chronic hypoxia: just ASIC-ness?
    J Physiol. 2021 Sep 17. doi: 10.1113/JP282325.
    PubMed    


  98. XIONG M, Jain PP, Chen J, Babicheva A, et al
    Mouse model of experimental pulmonary hypertension: Lung angiogram and right heart catheterization.
    Pulm Circ. 2021;11:20458940211041512.
    PubMed    
    Abstract available

  99. LUO L, Chen Q, Yang L, Zhang Z, et al
    MSCs Therapy Reverse the Gut Microbiota in Hypoxia-Induced Pulmonary Hypertension Mice.
    Front Physiol. 2021;12:712139.
    PubMed    
    Abstract available

  100. SIDDIQUE M, Nawaz MK, Khalid MB, Rai A, et al
    Right to Left Intrapulmonary Shunt in a Case with COVID-19-associated Pneumonia.
    J Coll Physicians Surg Pak. 2021;31:S23-S25.
    PubMed    
    Abstract available

  101. EVLAKHOV VI, Poiasov IZ, Ovsiannikov VI
    [Pulmonary artery denervation in pulmonary hypertension: physiological and clinical aspects].
    Angiol Sosud Khir. 2021;27:16-21.
    PubMed    
    Abstract available

  102. LAMMERS AE, Apitz C, Michel-Behnke I, Koestenberger M, et al
    A guide to echocardiographic assessment in children and adolescents with pulmonary hypertension.
    Cardiovasc Diagn Ther. 2021;11:1160-1177.
    PubMed    
    Abstract available

  103. HERBERG U, Knies R, Muller N, Breuer J, et al
    Altitude exposure in pediatric pulmonary hypertension-are we ready for (flight) recommendations?
    Cardiovasc Diagn Ther. 2021;11:1122-1136.
    PubMed    
    Abstract available

  104. KAESTNER M, Apitz C, Lammers AE
    Cardiac catheterization in pediatric pulmonary hypertension: a systematic and practical approach.
    Cardiovasc Diagn Ther. 2021;11:1102-1110.
    PubMed    
    Abstract available

  105. LATUS H, Meierhofer C
    Role of cardiovascular magnetic resonance in pediatric pulmonary hypertension-novel concepts and imaging biomarkers.
    Cardiovasc Diagn Ther. 2021;11:1057-1069.
    PubMed    
    Abstract available

  106. KRAMER J, Beer M, Kaestner M, Bride P, et al
    Moyamoya disease associated with pediatric pulmonary hypertension-a case report.
    Cardiovasc Diagn Ther. 2021;11:1052-1056.
    PubMed    
    Abstract available

  107. LAMMERS AE, Apitz C
    Update from the World Symposium on Pulmonary Hypertension 2018: does the new hemodynamic definition of pediatric pulmonary hypertension have an impact on treatment strategies?
    Cardiovasc Diagn Ther. 2021;11:1048-1051.
    PubMed    
    Abstract available

  108. APITZ C, Lammers AE
    Pediatric pulmonary hypertension.
    Cardiovasc Diagn Ther. 2021;11:1023-1027.
    PubMed    


  109. DURU A, Madu AJ, Okoye H, Nonyelu C, et al
    Variations and characteristics of the various clinical phenotypes in a cohort of Nigerian sickle cell patients.
    Hematology. 2021;26:684-690.
    PubMed    
    Abstract available

  110. PINTO FF
    Percutaneous closure of patent ductus arteriosus: A standard procedure with new perspectives.
    Rev Port Cardiol (Engl Ed). 2021;40:569-571.
    PubMed    


  111. CALLEJO M, Morales-Cano D, Mondejar-Parreno G, Barreira B, et al
    Restoration of Vitamin D Levels Improves Endothelial Function and Increases TASK-Like K(+) Currents in Pulmonary Arterial Hypertension Associated with Vitamin D Deficiency.
    Biomolecules. 2021;11.
    PubMed    
    Abstract available

  112. CERECEDO D, Martinez-Vieyra I, Lopez-Villegas EO, Hernandez-Cruz A, et al
    Heterogeneity of neutrophils in arterial hypertension.
    Exp Cell Res. 2021;402:112577.
    PubMed    
    Abstract available

  113. BURGOYNE DS
    Reducing economic burden and improving quality of life in pulmonary arterial hypertension.
    Am J Manag Care. 2021;27.
    PubMed    
    Abstract available

  114. GALE S
    The evolving treatment landscape of pulmonary arterial hypertension.
    Am J Manag Care. 2021;27.
    PubMed    
    Abstract available

  115. LEVINE DJ
    Pulmonary arterial hypertension: updates in epidemiology and evaluation of patients.
    Am J Manag Care. 2021;27.
    PubMed    
    Abstract available

  116. RAEVENS S, Boret M, De Pauw M, Fallon MB, et al
    Pulmonary Abnormalities in Liver Disease: Relevance to Transplantation and Outcome.
    Hepatology. 2021;74:1674-1686.
    PubMed    
    Abstract available

  117. OH S, Jang AY, Chae S, Choi S, et al
    Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension.
    Sci Rep. 2021;11:2012.
    PubMed    
    Abstract available

  118. KITTIPIBUL V, Blumer V, Angsubhakorn N, Hernandez GA, et al
    Phosphodiesterase-5 Inhibitors and Outcomes During Left Ventricular Assist Device Support: A Systematic Review and Meta-Analysis.
    J Card Fail. 2021;27:477-485.
    PubMed    
    Abstract available

  119. ENGLERT L, Stadlbauer C, Spaeth M, Hofmann HS, et al
    Evaluation of the combination of endothelin receptor antagonists (ERA) and phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension (PAH) in pathologic human pulmonary arteries in an ex-vivo organ bath model.
    Pulm Pharmacol Ther. 2021;66:101985.
    PubMed    
    Abstract available

  120. RAHAGHI FF, Allen RP, Balasubramanian VP, Chakinala MM, et al
    An expert panel delphi consensus statement on patient selection and management for transitioning between oral and inhaled treprostinil.
    Pulm Pharmacol Ther. 2021;66:101979.
    PubMed    
    Abstract available

  121. KLINGER JR, Chakinala MM, Langleben D, Rosenkranz S, et al
    Riociguat: Clinical research and evolving role in therapy.
    Br J Clin Pharmacol. 2021;87:2645-2662.
    PubMed    
    Abstract available

  122. NAJJAR E, Lund LH, Hage C, Nagy AI, et al
    The differential impact of the Left Atrial pressure components on Pulmonary Arterial Compliance-Resistance relationship in Heart Failure.
    J Card Fail. 2020 Sep 18. pii: S1071-9164(20)30955.
    PubMed    
    Abstract available

  123. EDMONSTON DL, Matsouaka R, Shah SH, Rajagopal S, et al
    Noninvasive Risk Score to Screen for Pulmonary Hypertension With Elevated Pulmonary Vascular Resistance in Diseases of Chronic Volume Overload.
    Am J Cardiol. 2021 Sep 6. pii: S0002-9149(21)00774.
    PubMed    
    Abstract available

  124. LANG IM, Thurner S
    Computer modeling to predict balloon pulmonary angioplasty success.
    Am J Physiol Heart Circ Physiol. 2021;321:H567-H568.
    PubMed    


  125. DE MAN FS, Vonk-Noordegraaf A
    The magic of communication: the need to study organ and cell communication in pulmonary arterial hypertension-induced right heart failure.
    Am J Physiol Lung Cell Mol Physiol. 2021;321:L634-L636.
    PubMed    


  126. NAKAHARA M, Ito H, Skinner JT, Lin Q, et al
    The inflammatory role of dysregulated IRS2 in pulmonary vascular remodeling under hypoxic conditions.
    Am J Physiol Lung Cell Mol Physiol. 2021;321:L416-L428.
    PubMed    
    Abstract available

  127. ZHENG Z, Chen R, Zhang N, Zhuang C, et al
    Pulmonary Hypertension: A Predictor of Lung Cancer Prognosis?
    Am J Respir Crit Care Med. 2021 Sep 2. doi: 10.1164/rccm.202105-1256.
    PubMed    


  128. EUL B, Cekay M, Pullamsetti SS, Tello K, et al
    Reply to: Pulmonary Hypertension: A Predictor of Lung Cancer Prognosis?
    Am J Respir Crit Care Med. 2021 Sep 2. doi: 10.1164/rccm.202106-1411.
    PubMed    


  129. ZHANG Y, Michelakis ED
    A Phase-2 NIH-sponsored Randomized Clinical Trial of Rituximab in Scleroderma-associated Pulmonary Arterial Hypertension Did Not Reach Significance for Its Endpoints: End of Story? Not So Fast!
    Am J Respir Crit Care Med. 2021;204:123-125.
    PubMed    


  130. WANG G, Wen B, Ren X, Li E, et al
    Generation of Pulmonary Endothelial Progenitor Cells for Cell-based Therapy Using Interspecies Mouse-Rat Chimeras.
    Am J Respir Crit Care Med. 2021;204:326-338.
    PubMed    
    Abstract available

  131. ZAMANIAN RT, Badesch D, Chung L, Domsic RT, et al
    Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial.
    Am J Respir Crit Care Med. 2021;204:209-221.
    PubMed    
    Abstract available

  132. ULRICH S, Mathai SC
    Performance Under Pressure: The Relevance of Pulmonary Vascular Response to Exercise Challenge in Scleroderma.
    Chest. 2021;159:481-483.
    PubMed    


  133. SYNN AJ, Li W, Hunninghake GM, Washko GR, et al
    Vascular Pruning on CT and Interstitial Lung Abnormalities in the Framingham Heart Study.
    Chest. 2021;159:663-672.
    PubMed    
    Abstract available

  134. GALLINI JW, Benkeser D, Cui X, Shah AJ, et al
    Pulmonary hypertension: a new vascular complication of diabetes?
    Chest. 2021 Sep 16. pii: S0012-3692(21)03863-0. doi: 10.1016/j.chest.2021.
    PubMed    


  135. OPPEGARD LJ, Hedstrom G, Levene J, Desai S, et al
    A 44-Year-Old Man Presenting With Massive Hemoptysis and Dyspnea.
    Chest. 2021;159:e237-e241.
    PubMed    
    Abstract available

  136. TATAH JH, Weir EK, Prins KW, Thenappan T, et al
    A Case Report of Portopulmonary Hypertension Precipitated by Transjugular Intrahepatic Portosystemic Shunt.
    Chest. 2021;159:e193-e196.
    PubMed    
    Abstract available

  137. CERTAIN MC, Chaumais MC, Jais X, Savale L, et al
    Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C.
    Chest. 2021;159:1197-1207.
    PubMed    
    Abstract available

  138. OMURA J, Habbout K, Shimauchi T, Wu WH, et al
    Identification of The Long Non-Coding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
    Circulation. 2020 Jul 23. doi: 10.1161/CIRCULATIONAHA.120.047626.
    PubMed    
    Abstract available

  139. GREDIC M, Wu CY, Hadzic S, Pak O, et al
    Myeloid cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice.
    Eur Respir J. 2021 Sep 2. pii: 13993003.01153-2021.
    PubMed    
    Abstract available

  140. DECLERCQ M, Treps L, Bousfia S, Carmeliet P, et al
    Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension.
    Eur Respir J. 2021;58.
    PubMed    


  141. SAVALE L, Akagi S, Tu L, Cumont A, et al
    Serum and pulmonary uric acid in pulmonary arterial hypertension.
    Eur Respir J. 2021;58.
    PubMed    
    Abstract available

  142. GUPTA A, Kabra M, Gupta N
    Combined Methylmalonic Aciduria and Homocystinuria Presenting as Pulmonary Hypertension.
    Indian J Pediatr. 2021 Sep 12. pii: 10.1007/s12098-021-03938.
    PubMed    
    Abstract available

  143. OLSSON KM, Kamp JC, Hoeper MM
    Pregnancy in PAH: Reality is changing.
    J Heart Lung Transplant. 2021;40:395-396.
    PubMed    


  144. KEUSTERS L, Purna J, Deshpande P, Mertens L, et al
    Clinical validity of systemic arterial steal among extremely preterm infants with persistent patent ductus arteriosus.
    J Perinatol. 2020 May 11. pii: 10.1038/s41372-020-0663.
    PubMed    
    Abstract available

  145. LOPATA SM, Slaughter JC, Gillam-Krakauer M, Reese J, et al
    The patent ductus arteriosus management debate: it's not over yet.
    J Perinatol. 2021;41:923-925.
    PubMed    


  146. MONTANI D, Girerd B, Humbert M
    [Screening for pulmonary veno-occlusive disease: A specific approach].
    Rev Mal Respir. 2021;38:215-216.
    PubMed    


  147. WAKABAYASHI SI, Joshita S, Kimura K, Motoki H, et al
    Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease.
    PLoS One. 2021;16:e0249435.
    PubMed    
    Abstract available

  148. MASAKI T, Okazawa M, Asano R, Inagaki T, et al
    Aryl hydrocarbon receptor is essential for the pathogenesis of pulmonary arterial hypertension.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    
    Abstract available

  149. GAIRHE S, Awad KS, Dougherty EJ, Ferreyra GA, et al
    Type I interferon activation and endothelial dysfunction in caveolin-1 insufficiency-associated pulmonary arterial hypertension.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;